3,5-dihydroxyphenylglycine has been researched along with bisindolylmaleimide i in 1 studies
Studies (3,5-dihydroxyphenylglycine) | Trials (3,5-dihydroxyphenylglycine) | Recent Studies (post-2010) (3,5-dihydroxyphenylglycine) | Studies (bisindolylmaleimide i) | Trials (bisindolylmaleimide i) | Recent Studies (post-2010) (bisindolylmaleimide i) |
---|---|---|---|---|---|
301 | 1 | 61 | 1,198 | 1 | 174 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, SY; Park, ES; Youn, DH | 1 |
1 other study(ies) available for 3,5-dihydroxyphenylglycine and bisindolylmaleimide i
Article | Year |
---|---|
NMDA receptor, PKC and ERK prevent fos expression induced by the activation of group I metabotropic glutamate receptors in the spinal trigeminal subnucleus oralis.
Topics: Animals; Benzoates; Extracellular Signal-Regulated MAP Kinases; Female; Flavonoids; Glycine; Indoles; Male; Maleimides; Neurons; Protein Kinase C; Proto-Oncogene Proteins c-fos; Rats; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Resorcinols; Trigeminal Nucleus, Spinal | 2010 |